Literature DB >> 9210610

Autonomic dysfunction in patients with non-alcoholic chronic liver disease.

M I Oliver1, R Miralles, J Rubíes-Prat, X Navarro, J M Espadaler, R Solá, M Andreu.   

Abstract

AIMS: To assess the presence of autonomic neuropathy in patients with non-alcoholic chronic liver disease and its relationships with the severity of liver damage.
METHODS: Thirty non-alcoholic patients with chronic liver disease and 26 healthy control subjects were studied. The silicone imprint technique was used to quantify the number of functioning sweat glands in order to assess peripheral sympathetic dysfunction. Heart rate variations in response to deep breathing at 6 per minute (deltaR6), to a Valsalva maneuver, and with orthostatism (RRmax/RRmin) were determined to assess parasympathetic vagal function.
RESULTS: Mean values for autonomic tests were significantly lower in the group of patients with non-alcoholic chronic liver disease than in the control subjects. The number of activated sweat glands in the foot was abnormal in 19 (63%) patients. Among vagal tests, Valsalva ratio was abnormal in 14 (46%) and deltaR6 in 11 (36%) patients with liver disease. Vagal neuropathy (two or more abnormal heart rate tests) was definite in nine patients (30%).
CONCLUSIONS: A high prevalence of abnormalities in both sympathetic and parasympathetic function tests, with a poor relationship with liver function parameters, has been found in patients with non-alcoholic chronic liver disease.

Entities:  

Mesh:

Year:  1997        PMID: 9210610     DOI: 10.1016/s0168-8278(97)80458-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  13 in total

Review 1.  Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.

Authors:  S Møller; J H Henriksen
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

2.  Altered circadian hemodynamic and renal function in cirrhosis.

Authors:  Suthat Liangpunsakul; Rajiv Agarwal
Journal:  Nephrol Dial Transplant       Date:  2017-02-01       Impact factor: 5.992

3.  Effects of orthotopic liver transplantation on the corrected QT interval in patients with end-stage liver disease.

Authors:  Elizabeth J Carey; David D Douglas
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

4.  Patients with autonomic neuropathy are more likely to develop hepatic encephalopathy.

Authors:  Anurag Maheshwari; Anil Thomas; Paul J Thuluvath
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

Review 5.  Cardiopulmonary complications in chronic liver disease.

Authors:  Soren Moller; Jens H Henriksen
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

6.  Autonomic and sensory nerve dysfunction in primary biliary cirrhosis.

Authors:  Katalin Keresztes; Ildikó Istenes; Aniko Folhoffer; Peter L Lakatos; Andrea Horvath; Timea Csak; Peter Varga; Peter Kempler; Ferenc Szalay
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

7.  Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults.

Authors:  Piero Portincasa; Antonio Moschetta; Massimo Berardino; Agostino Di-Ciaula; Michele Vacca; Giuseppe Baldassarre; Anna Pietrapertosa; Rosario Cammarota; Nunzia Tannoia; Giuseppe Palasciano
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

8.  Effect of biliary cirrhosis on neurogenic relaxation of rat gastric fundus and anococcygeus muscle: role of nitric oxide pathway.

Authors:  Mehdi Ghasemi; Ali Reza Karimollah; Bardia Bakhtiari; Abbas Ghasemi; Leila Moezi; Arash Bahremand; Pouya Ziaei; Ahmad Reza Dehpour
Journal:  Dig Dis Sci       Date:  2014-06-05       Impact factor: 3.199

Review 9.  Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications.

Authors:  Csaba Matyas; György Haskó; Lucas Liaudet; Eszter Trojnar; Pal Pacher
Journal:  Nat Rev Cardiol       Date:  2020-09-30       Impact factor: 32.419

10.  Sialadenosis in patients with advanced liver disease.

Authors:  James Guggenheimer; John M Close; Bijan Eghtesad
Journal:  Head Neck Pathol       Date:  2009-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.